Vanessa Yanez, PhD (@VYBioDesign) header
Vanessa Yanez, PhD (@VYBioDesign) profile picture

PhD @TuftsUniversity | @BU_tweets alum| biomedical/genome engineer| Latinx 🇪🇨🇺🇸 #retina #genetherapy #CRISPRdelivery #firstgen

Boston, MA
Joined February 2012
Photo by Vanessa Yanez, PhD (@VYBioDesign)Photo by Vanessa Yanez, PhD (@VYBioDesign)Photo by Vanessa Yanez, PhD (@VYBioDesign)Photo by Vanessa Yanez, PhD (@VYBioDesign)Photo by Vanessa Yanez, PhD (@VYBioDesign)Photo by Vanessa Yanez, PhD (@VYBioDesign)Photo by Vanessa Yanez, PhD (@VYBioDesign)Photo by Vanessa Yanez, PhD (@VYBioDesign)Photo by Vanessa Yanez, PhD (@VYBioDesign)Photo by Vanessa Yanez, PhD (@VYBioDesign)
Vanessa Yanez, PhD retweeted
I am humbled by the response to this and I have one ask. Can you share this post so that we can get 75K likes? It is the most impactful thing @sabrevaya and I can do to save our democracy.
This quoted post is unavailable.
87
2,518
81
6,829
193,223
Delivery, delivery, delivery! Join us in Siracusa, Italy from April 4-7 to discuss new advances in nucleic acid delivery and how to solve the remaining challenges! Don't miss this opportunity. Abstract deadline is March 15, 2024. Register here: engconf.us/conferences/biote…
1
5
25
1,687
Vanessa Yanez, PhD retweeted
Just heard from another family that we've partnered with and things are looking good. while just an observational study, kids are improving while on a drug that we discovered in a fly screen.
2
2
4
70
8,561
Vanessa Yanez, PhD retweeted
On the International Day of Women and Girls in Science, let’s help girls everywhere pursue careers in science, technology, engineering and math. Our world is better with their ideas and perspectives.
4,900
10,718
700
69,261
9,090,994
Vanessa Yanez, PhD retweeted
1) Your well-being must be your priority.   It's easy to become so focused on the end goal that we sacrifice all to get there.   But if you arrive at your destination as a hollow shell of who you are, you have missed the mark of building a better life in the very pursuit of it.
4
28
3
139
Vanessa Yanez, PhD retweeted
The first molecular age of the eye clock: identifying ~6,000 proteins (via liquid biopsies from 120 patients) and multiomics #AI cell.com/cell/fulltext/S0092… @CellCellPress
45
2
166
42,440
🚨 Today, we’re thrilled to share our study expanding the gene editing toolbox to enable virtually any kind of edit in gene transcripts at the order of thousands of bases. A thread 🧵👇(1/n) biorxiv.org/content/10.1101/…
13
112
26
457
156,529
Vanessa Yanez, PhD retweeted
Appreciation Post Alert!Last Thursday in our #S2P2, we had the chance to share with the Tufts #alumni that paved the road for @TuftsSACNAS: Dr. Jesús A. Romo, and @VYBioDesign. Thanks for setting up the stepping stone for our #organization! @SACNAS #dei #appreciationpost
1
2
11
875
Vanessa Yanez, PhD retweeted
Amazing S2P2 Alumni Oral Presentations! #S2P2_Symposium #SACNAS Special shout out to old SACNAS/SPINES leader @VYBioDesign
1
3
7
1,685
Vanessa Yanez, PhD retweeted
Affirmative action was never a complete answer in the drive towards a more just society. But for generations of students who had been systematically excluded from most of America’s key institutions—it gave us the chance to show we more than deserved a seat at the table. In the wake of the Supreme Court’s recent decision, it’s time to redouble our efforts.
I wanted to share some of my thoughts on today's Supreme Court decision on affirmative action:
25,137
23,491
2,938
130,256
46,960,108
Vanessa Yanez, PhD retweeted
Since the discovery of CRISPR-Cas systems, people have wondered if a similar type of system exists in eukaryotes. Today, we report in @Nature the characterization of Fanzor, a eukaryotic RNA-guided system that can be reprogrammed for human genome editing. nature.com/articles/s41586-0…
40
1,650
211
5,232
707,195
Vanessa Yanez, PhD retweeted
As a Ph.D. student, my income surpassed that of my parents combined. Although leaving them behind left me with a sense of guilt, it also filled me with pride to be able to help. As first-generation students, we often experience these conflicting emotions throughout our journey.
8
23
6
222
33,085
Additionally, this data is another reason why medical schools should feel morally OBLIGATED to ensure a more diverse pipeline of physicians. They should be investing in programs in low-income communities to ensure the physician population accurately represents the patient pop.
2
11
69
3,962
Vanessa Yanez, PhD retweeted
Has a similar study ever been done for US Congressman and Senators? What about CEOs?
2
1
49
9,242
As someone from an extremely poor background who excelled academically (perfect scores in math meets, captain of mock trial team, award for highest state test scores, etc), this merit argument is a joke. It was hard at every level for me to succeed in academic environments:
I believe in MERIT. The issue is that historical systems in the US excluded the poor, women, and racially minoritized groups from competing. Multiple practices have allowed the impacts of this exclusion to persist. 1/5.
3
160
29
728
184,702
In grad school, I had independent funding the entire time but only presented my research once at a scientific meeting because I could not afford to wait for reimbursement.
1
10
144
9,893
Not here to change anyone's mind. All I ask is that when women from minoritized group win, despite being so encumbered by the system, YOU who champion MERIT would lift THEM up, celebrate THEIR success, and promote THEM. They ran a far harder race and still won! -MERIT. 4/5.
1
30
2
197
16,105
Vanessa Yanez, PhD retweeted
I have always considered my work in science to be a service to my community. Sickle cell disease commonly affects people of African descent, so it has been the honor of a lifetime to contribute to, and now lead, efforts to establish potentially therapeutic strategies for SCD.
4
22
1,035
Vanessa Yanez, PhD retweeted
Very excited to announce the publication of our corrective prime editing strategy for sickle cell disease! It was an honor to lead this work with David’s support and in collaboration with colleagues from St. Jude and the NIH.
Today we report in @natBME ex vivo prime editing of blood stem cells from sickle cell disease (SCD) patients, followed by transplantation into mice, correcting the SCD mutation to wild-type hemoglobin and rescuing SCD blood abnormalities. drive.google.com/file/d/11dc… 1/12
10
32
158
36,929